chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My arm was sore from that Fri. night until Sunday 8/8. The following week 8/15 I awoke to itching/scratching my neck. Followed my other upper parts of my body chest and arms up. As I scratched bumps would appear.  I been taking Benadryl and it seems to be getting better(leaving) . I have scratched less today.
About 15 minutes after vaccine, started to feel heaviness in chest, pounding and hot.  Layed on a liter.  VS monitored.  Stated feeling better, but wanted to continue to lay down.  About 20-25 minutes after symptoms started, BP 140/73, HR 96 and no s/s of dizziness or lightheadedness.  About 1 hour later, patient got up to leave and felt vertigo and had to sit back down. Symptoms then resolved.
Pt c/o pressure in the head,pt takes antianxiety and antihypertensive medication,pt monitor for 24 mins and denies any symptoms.
I experienced the following symptoms: Fatigue, Palpitations and Dizziness. I went to the Emergency Room because of these symptoms and was admitted to Cardiac Observation and did the following tests: EKG, CAT Scan (Neck), Ultrasound (Neck), Lab work and they ordered 30 days of heart monitoring. At that time the medical staff did not know what was wrong with me.
Severe vomiting, blood pressure spiked at172/157 pulse rate 148, then severe hot flushing sensation ending in being soaking wet and clammy feeling, dizziness and feeling like I was passing out. Sat down on toilet, called my daughter and all I could say was help, I think I'm passing out. She found me passed out on the toilet , got me to wake up but not coherent. She called 911 and I was checked and taken to emergency room with diagnosis of dehydration caused by the vomiting.
Generally didn´t feel well; Weak; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MALAISE (Generally didn´t feel well) and ASTHENIA (Weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MALAISE (Generally didn´t feel well) and ASTHENIA (Weak). At the time of the report, MALAISE (Generally didn´t feel well) and ASTHENIA (Weak) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Mother called clinic on 10/27 for immunization reaction. Received vaccines on 10/25. Spoke to mother, states child looks like she had a reaction to vaccines on both of her legs that started on Wednesday morning.. Received proquad on right leg and kinrix on left leg. Right leg has little welts and redness, says its a circular shape about 4 inches. Some welts look fluid filled. No drainage, no bleeding. Left leg looks likes is red circle, about 3 in.. Feels warm to touch, not hard. No fevers, tmax 99.9. able to walk just fine, doesn't seem bothered by it. Has uri sx. No s/s of resp distress. Otherwise acting appropriately.
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA 11/15/2022 ANEMIA DUE TO BLOOD LOSS
Information has been received from a lawyer regarding a case in litigation concerning a 34 year old male patient (born on date reported as 17380). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster related conditions. On or about 12-MAY-2009, the patient was administered ZOSTAVAX by a healthcare provider (lot# and route unknown). On or about 24-SEP-2014, the patient was treated by a healthcare provider for shingles as a result of vaccination with ZOSTAVAX.  The outcome of the event was unknown. Additional information has been requested.
This spontaneous report as received from a pharmacist refer to an unspecified patient of unknown age. On 16-SEP-2014 the patient was vaccinated with an expired dose of RECOMBIVAX HB adult, lot # J014312, Expiration Date 07-SEP-2014 (dose, frequency and route unknown). No adverse effect reported. Additional information has been requested.
Body aches, chills, cough, headache, nausea, soreness and swelling of L arm pit.
her chest feel tight also felt like her breathing is off.; her chest feel tight also felt like her breathing is off.; This is a spontaneous report from a Pfizer sponsored program COVAX US support from a non-contactable female consumer (patient). A female patient of unspecified age received first dose of bnt162b2 (Pfizer COVID-19 Vaccine, Solution for Injection), via an unspecified route on 16Apr2021, as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient experienced her chest feel tight also felt like her breathing is off. She wanted to know could she wait longer than the 21 days and how much longer could she wait. The clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
given / Boostrix / subcutaneously in the left arm.; This case was reported by a consumer via call center representative and described the occurrence of intramuscular formulation administered by other route in a 52-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 8th December 2020, the patient received Boostrix (subcutaneous). On 8th December 2020, unknown after receiving Boostrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were provided as follows: The patient reported case for herself. The age at vaccination was not reported, however could be 51 or 52 years. The patient was given an unknown formulation of Boostrix subcutaneously in the left arm, which led to intramuscular formulation administered by other route. The reporter did not consent to follow up.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Sep2022 as dose 5 (booster), single (Lot number: GJ2524) at the age of 66 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hypercholesterolemia" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "Known allergies: eggs" (unspecified if ongoing). Concomitant medication(s) included: BUSPIRONE HCL, start date: 01May2021. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures included Paxlovid from 05Aug2023 to 09Aug2023 were taken as a result of drug ineffective, covid-19.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Large red area with fever to injection site of DTaP (lot DTPa557A2), Also fever,nausea, vomiting and diarrhea.
Hypotonic/hyporesponsive-within two hours of vaccine lasting approximately 40 hrs. Fever 100 deg F (rectal) within one hour of vaccine lasting approximately 42 hrs. Gave Tylenol  and mainly following innoculation and continues every four hours. many visits to dr's office thee two days. DTaP=only vaccine given. Also tired giving Motrin but this caused severe screaming lasting approximately 20 to 30 minutes each time.
I started having hand tremors and ignored thinking it was hunger effects. After 2 months, I had trouble sleeping, gained weight, experienced scanty periods, sweat more than usual and sensitive to heat, fatigue and the one symptom that sent me to hospital were my swollen eyes. After visiting the hospital and carrying out some tests, it was confirmed I have thyroid.  I had thyroid for about 4 months without treatment as I didn't know what it was. I have been on medication for about 1 week and that journey has not been easy considering I do not have health insurance. This is a life-long condition that I currently cannot afford and I will need a permanent solution soon.
he is disabled and has congestive heart failure.; This is a spontaneous report from a contactable consumer (patient). A male patient (age: 74, unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated he was disabled and had congestive heart failure. The patient stated that he read the CDC had decided to only give one shot, everything he read on the website saying designed for 2 doses of the covid 19 vaccine. He received his shot and they might not be able to give 2 doses. The outcome of event was unknown.  Information on the Lot/batch number has been requested.
Patient states that she turned red, blochy from the chest up to her head and developed a headache. BP was 16/90. Patient went to the ED and was given Benadryl, Tylenol and Ibuprofen. Patient states that her symptoms resolved by the time she left the ED.
Patient had a COVID vaccine on 3/12/21, this was her Second dose of Mederna vaccine. She states she had a scrap on her right elbow 4 hours after she states it turned red and swelled up. She then scrapped her left pointer finger and that swelled and turned red and going up just past her wrist.  She states these are really improving but the swelling and itching around her left eye is getting worse. She feels her nose feels swollen. She states her eye is matted shut in the AM. She feels fatigued.
fever ranging from 101 to 104; constant crying and runny nose; mom states pt has a swollen neck and keeps putting hands over ears;
The vial was initially stored in the refrigerator on 25Aug2022 and administered on 26Sep2022; No adverse event; beyond used date was on 24Sep2022 and they used it and made an error, Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (beyond used date was on 24Sep2022 and they used it and made an error, Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25Aug2022 and administered on 26Sep2022) and NO ADVERSE EVENT (No adverse event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Sep-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (beyond used date was on 24Sep2022 and they used it and made an error, Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25Aug2022 and administered on 26Sep2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (beyond used date was on 24Sep2022 and they used it and made an error, Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25Aug2022 and administered on 26Sep2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (beyond used date was on 24Sep2022 and they used it and made an error, Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25Aug2022 and administered on 26Sep2022).    No concomitant medication were reported.  It was reported that one of the vials beyond used date was on 24-Sep-2022 and they used it and made an error. Four patients were given doses from that vial (Monovalent). Individual vial of size 2.5 ml. The vial was initially stored in the refrigerator on 25-Aug-2022. The vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-651828, US-MODERNATX, INC.-MOD-2022-651830, US-MODERNATX, INC.-MOD-2022-651832 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-651828:same reporter US-MODERNATX, INC.-MOD-2022-651830:same reporter US-MODERNATX, INC.-MOD-2022-651832:same reporter
Information has been received on 09/13/2001 from a registered nurse concerning a child who "this summer" was vaccinated with a dose of hep A vaccine. Subsequently, the chiid had test results of anti-HAV, positive IgW. The pt did not seek medical attention. In follow-up, the reporter "did not think this is an AE." No further info is expected.
Dizziness, nausea, hives on arm (left) and chest that progressed over a few hours, tight chest, tingling lips, itchiness on face, back and stomach. Went to ER was given BENADRYL 50 mg and DECADRON. Itching stopped but returned next morning.
2/3/21Pt received the2nd dose Moderna and at 3pm developed body aches.  6 pm Headache, fever 101.8 administered per self  Ibprofen 400 mg. 2/4/21 12am -patient began sweating and chills, temperature 102.4, body aches and vomiting. 2/4/21  6am B/P 196/121, SOB, Chest pain called ambulance and to ER  .  Patient stated "received  steroids and observed for 4 hours and discharged from ER.
pain in stomach, pain in joints above waist( elbows, wrists, shoulders), flushed with sweating, some muscle aches in arms, fever and fatigue approximately 1  1/2 hours after inoculated. Took 1000 mg acetaminophen and symptoms  mostly resolved in about 2 hours. Some fatigue still present next day. No headache, no shivering and only very slight nausea.
horrible itching from the inside out. My own sweat makes me itch; I have never had skin allergies in my life and I took a test and I reacted to everything even the saline; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MULTIPLE ALLERGIES (non-serious) with onset Nov2021, outcome "not recovered", described as "I have never had skin allergies in my life and I took a test and I reacted to everything even the saline"; PRURITUS (non-serious) with onset Nov2021, outcome "not recovered", described as "horrible itching from the inside out. My own sweat makes me itch". Relevant laboratory tests and procedures are available in the appropriate section.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Medical assistant administered 2.5 ml of vaccine on 6/30/22 Started bruising to Rt-arm on 7/1/2022.
This spontaneous report as received from a nurse refers to a 17 year old female patient. The reporter stated that on 08-AUG-2014 PROQUAD (route of administration and dose unknown) was inadvertently administered to an unspecified 17 year old female patient. Pertinent medical history and concomitant medications were unspecified by the reporter. No adverse effect reported. The outcome of the events was unknown. No further information provided. Additional information has been requested.
I got very ill with flu-like symptoms after both doses. I had my first dose in May and the 2nd in June 2021. After the 1st dose I was sick for about 8 days. I had a high fever and terrible chills. All my muscles ached. It was extreme.  The 4th day I started to feel gradually better. I didn?t feel totally normal for 8-9 days. After the 2nd dose I also had extreme flu-like symptoms but that time they only lasted about 3 days and I felt normal after about 5 days. Fast forward to August. My thumbs no longer work properly. I have trigger thumbs in both hands. It started in the  left hand. Then, about 4 weeks later I have the same problem in my right hand. I went to an urgent care center and the doctor determined that I have inflammation in the muscles / area at the base of both thumbs. If I bend my thumbs they bet stick in place and it is extremely painful. Initially I thought that this may have been caused by my herceptin & perjeta infusions- but get this - my husband developed the exact same problems in both of his thumbs! We didn?t change anything about our routines / use of our hands. The only thing we both did recently that was different is get the Moderna vaccine. He got his doses in April & May 2021. He said his thumbs feel better than they did a couple months ago, but he hasn?t regained full usage and is still in pain when he moves them. We are both executives at companies with office jobs. I am reporting this side effect to you in good faith with the hope that you will research it. My husband and I have both been strict vegans for more than 20 years and are healthy food nuts. We take raw vitamin B12, a blood builder,  algae oil, and magnesium. We eat mostly organic. While I recently recovered from cancer, I am otherwise in perfect health. My husband and I both look 10 years younger than our ages (he is 46). It is so bizarre that we both experienced the exact same side effect. My husband also had a strong flu-like reaction to the 2nd dose of the vaccine, though his symptoms subsided more quickly than mine. The only theory we have is that we both have very good immune systems and are very healthy people, so perhaps our immune response went into overdrive and attacked healthy parts of our bodies. Neither of us is in the medical profession (I am an accountant - he is a commodities buyer), so we are just guessing. In any case, I hope this information helps the trained scientists to research the potential cause.  We try to have a sense of humor about no one on the house being capable of opening jars anymore. I am just thankful that we both have jobs where an inability to use our thumbs is a nuisance but doesn?t prevent us from working.
who diagnosed shingles; rash in the arm, which was painful; rash in the arm, which was painful and itchy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number 97LJ7) for prophylaxis.   On 04-AUG-2023, the patient received the 1st dose of Shingrix (unknown arm). On 08-AUG-2023, 4 days after receiving Shingrix, the patient experienced shingles (Verbatim: who diagnosed shingles), painful rash (Verbatim: rash in the arm, which was painful) and itchy rash (Verbatim: rash in the arm, which was painful and itchy).  The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). The outcome of the shingles was unknown and the outcome of the painful rash and itchy rash were not reported.   It was unknown if the reporter considered the shingles, painful rash and itchy rash to be related to Shingrix.     It was unknown if the company considered the shingles, painful rash and itchy rash to be related to Shingrix.   Additional Information: GSK Receipt date: 16-AUG-2023 A pharmacist reported that a patient got the 1st dose of Shingrix on 04 August 2023.  On 08 August 2023, the patient noticed a rash in the arm, which was painful and itchy.  On the 14th, the patient went to the doctor, who diagnosed shingles, and prescribed antivirals to the patient.  The reporter consented to follow up.
patient presented to emergency department on 2/21/22 with shortness of breath, fever , cough and abdominal pain patient was admitted for further management of abdominal pain patient was found to be covid-19 positive on 2/21/22 patient did not require treatment for symptoms associated with covid-19. patient was discharged to home on 2/27/22
numbness and itching in the roof of mouth; numbness and itching in the roof of mouth; This is a spontaneous report from a contactable healthcare professional.  A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ 1685), intramuscular on the left arm on Dec2020 at single dose for COVID-19 immunisation.  Medical history included hypertension and GERD.  Concomitant medication included metoprolol, dexlansoprazole, ondansetron and propranolol.  The patient previously took gadolinium and midazolam and experienced known allergies: gadolinium and midazolam.  The patient experienced numbness and itching in the roof of mouth on Dec2020. Patient received BENADRYL as treatment. The outcome of the events was recovering.
Developed headache starting 7/31; on August 1 it became severe, and she developed fever and swelling at the site of injection
This case was reported by a healthcare professional and described the occurrence of swelling of legs in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced swelling of legs.  At the time of reporting the outcome of the swelling of legs was unspecified.  The healthcare professional made an initial report of swelling around the legs, see case A0883031A.  During the report it was stated that the healthcare professional's "colleague had two similar events over the past four weeks"; see case A0883035A.  The representative stated the provider has already reported the events via VAERS.